Profile avatar
opeyemiolabisi.bsky.social
Physician-Scientist, Adult nephrologist. Passionately seeking prevention & cure for APOL1 kidney disease.
16 posts 663 followers 277 following
Regular Contributor
Conversation Starter
Posts 20 Comments 10

Congratulations Dr. @opeyemiolabisi.bsky.social for being elected to the American Society for Clinical Investigation (ASCI)! @the-asci.bsky.social medicine.duke.edu/news/two-duk...

submitted 5 days ago • 1 comment

Congratulations to Dr. Tomasi @AleTomasiMD on being appointed as the chief nephrology fellow for the academic year 2025-2026.

submitted 11 days ago • 0 comments

New from Dr Anika Lucas and colleagues in Kidney360 2nd Trimester Kidney Function and Adverse Pregnancy Outcomes among Patients with Lupus journals.lww.com/kid...

submitted 12 days ago • 0 comments

Face-to-face interactions often facilitate collaboration and innovation. Therefore, @dukekidney.bsky.social research retreat focused on ways to increase purposeful interaction and collaboration. It was a time well spent!

submitted 32 days ago • 0 comments

Happy to share this excellent editorial on our recent NEJM paper www.nejm.org/doi/10.1056/... by Simone @genetickidneydoc.bsky.social Simone you nailed it! www.nejm.org/doi/10.1056/... 🙏🏽

submitted 41 days ago • 0 comments

I am delighted to be elected as a member of The American Society for Clinical Investigation! I’m thankful for my dedicated lab team, mentors, supportive family & colleagues @the-asci.bsky.social @dukekidney.bsky.social @dukemedschool.bsky.social

submitted 49 days ago • 5 comments

😁 Delighted to have my copy of ‘The Body’s Keepers’📔personally signed by author, Dr. Paul Kimmel🖋️ . This📔offers both a historical perspective➕personal look at development of kidney failure treatments, highlighting advances along w/ ongoing challenges | #KidneyHealth | #Innovation 🏥 👉🏽 t.ly/7UuYT

submitted 53 days ago • 1 comment

Summer Undergraduate Program in Kidney Science (SUPerKS) provides talented students the unique opportunity to explore research and physician-scientist careers in the kidney field with exposure to the practice of medicine. hopkinsmedicine.org/nephrology/e... Applications due by February 1, 2025

submitted 58 days ago • 0 comments

JCI - Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice www.jci.org/articles/vie...

submitted 71 days ago • 0 comments

We featured Chideraa Emma-Ugwuoke an outstanding PRIME PUMP scholar in the Student Corner of the OPSD December Newsletter. He worked with @opeyemiolabisi.bsky.social. Click the link to learn more about Chideraa's summer research experience @dukemedschool.bsky.social. mailchi.mp/duke/opsd-de...

submitted 70 days ago • 0 comments

Hello there, #NephSky 🙂 Check out the December issue of KI! Topics include: 🔹#AKI after hair straightening 🔹RAS inhibition attenuates #FSGS in mice with #APOL1 risk variants 🔹A dual #GLP-1 and glucagon receptor agonist in #diabetickidneydisease 🔗doi.org/10.1016/j.kint.2024.10.006 #MedSky

submitted 78 days ago • 2 comments

How did the #APOL1 protective variant arise on the G2 haplotype? My initial guess was by independent mutational event, but look at this: a close proximity recombination event between G0 and G2. Read this report from Martin Pollak team to which we contributed #FSGS academic.oup.com/g3journal/ad...

submitted 78 days ago • 0 comments

What an inspiring conference!

submitted 80 days ago • 0 comments

Minus 10 days to the first ever, recurrent FSGS Conference! Registration is open for a few more days! Meet in person >60 patients/family members, Congressmen and Senators, and top scientists! ⬇️ @gbadegesinlab.bsky.social @kidneyomicsamps.bsky.social @opeyemiolabisi.bsky.social #rFSGS #nephsky

submitted 90 days ago • 1 comment

@genetickidneydoc.bsky.social it was delightful working with you and your excellent team on this perspective.

submitted 91 days ago • 0 comments

The final version of our paper www.nejm.org/doi/10.1056/... One APOL1 risk variant is associated with CKD & FSGS. We have a solid basis for new mechanistic studies in our journey to find durable cure for APOL1 KD @opeyemiolabisi.bsky.social @kidneyomicsamps.bsky.social @genetickidneydoc.bsky.social

submitted 96 days ago • 2 comments

Are your patients with APOL1 kidney disease on optimal doses of ACEi/ARB? See my new commentary on an interesting mouse-based study from Pollak lab #APOL1 @genetickidneydoc.bsky.social @nephrosparks.bsky.social @kidneyomicsamps.bsky.social @gbadegesinlab.bsky.social @dukekidney.bsky.social

submitted 97 days ago • 0 comments

I look forward to participating in this important conference!

submitted 98 days ago • 0 comments

rFSGS is a major cause of kidney tx loss. There is a need for multidisciplinary rethinking of how we are going to solve this. We are all looking forward to the Dec 9th meeting in DC @genetickidneydoc.bsky.social @isgd.bsky.social #ASPN @opeyemiolabisi.bsky.social @kidneyomicsamps.bsky.social

submitted 98 days ago • 0 comments

Coming from X to Bsky and reconnecting with friends and colleagues who also fled the toxicity feels like post-apocalypse. You made it out of the cave/bunker and discovered that many of your loved ones also made it🤓

submitted 98 days ago • 0 comments